Psoriasis treatment with vitamin D derivatives

Area of Science:

• Dermatology and endocrinology, focusing on vitamin D analogs.

Background:

• 1,25(OH)2 vitamin D3 and its synthetic derivatives (1,24(OH)2 vitamin D3, calcipotriol) influence keratinocyte proliferation and differentiation.
• Clinical studies indicate therapeutic potential for these vitamin D derivatives in treating psoriasis.

Purpose of the Study:

• To evaluate the efficacy and safety profiles of vitamin D3 derivatives in dermatological applications, particularly for psoriasis.
• To compare the risk of hypercalcemia associated with 1,25(OH)2 vitamin D3 versus its synthetic analogs.

Main Methods:

• Review of clinical trial data and pharmacological properties of 1,25(OH)2 vitamin D3, 1,24(OH)2 vitamin D3, and calcipotriol.
• Analysis of keratinocyte responses to these compounds.

Main Results:

• All three vitamin D derivatives demonstrate efficacy in managing psoriasis.
• Calcipotriol exhibits a significantly lower risk of hypercalcemia (100-200 times less) compared to 1,25(OH)2 vitamin D3.
• 1,24(OH)2 vitamin D3 may also present a reduced hypercalcemia risk.

Conclusions:

• Vitamin D3 analogs are effective in treating psoriasis.
• Calcipotriol is a viable therapeutic option for psoriasis, offering an improved safety profile regarding hypercalcemia.
• Marketed calcipotriol formulations provide an alternative to traditional topical treatments like glucocorticoids and dithranol.